Produced to the most demanding industry standards at dedicated facilities, Zephex® propellants are used around the globe.
This commitment to the highest levels of medical propellant quality is supported by a detailed understanding of customer requirements and experienced staff with many years of technical expertise.
BOSTON, Feb. 4, 2020 – Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use…
The University of Manchester has announced Melissa Pace as the third student to receive Koura’s Alasdair Sinclair Scholarship.